The British Society for Rheumatology biologics register

Annals of the Rheumatic Diseases

Volumn 64, Issue SUPPL. 4, 2005, Pages

  Watson, K ^a   Symmons, D ^a   Griffiths, I ^b   Silman, A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b British Society for Rheumatology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

CLINICAL PRACTICE; CONFERENCE PAPER; DISEASE SEVERITY; DRUG SPECIFICITY; DRUG SURVEILLANCE PROGRAM; HUMAN; INFORMATION PROCESSING; LONG TERM CARE; MEDICAL SOCIETY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIRHEUMATIC AGENTS; BIOLOGICAL PRODUCTS; GREAT BRITAIN; HUMANS; REGISTRIES; RHEUMATIC DISEASES; RHEUMATOLOGY; SOCIETIES, MEDICAL;

EID: 27444437191     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.042499     Document Type: Conference Paper

References (6)

1. National Institute for Clinical Excellence. Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. www.nice.org.uk/pdf/RA-PDF.pdf (accessed 31 March 2002) London, National Institute for Clinical Excellence, 2002.
2. Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 2002;46:3151-8.
3. Ekstrom K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum 2003;48:963-70.
4. Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L. Rheumatoid arthritis and malignant lymphomas [review]. Curr Opin Rheumatol 2004;16:254-61.
5. Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 1998;317:180-1.
6. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004;50:1740-51.